Research on the Evaluation of Technological Innovation Capability of China’s Biopharmaceutical Industry ()
ABSTRACT
Objective: To analyze the innovation capability of China’s biopharmaceutical industry to explore ways to
enhance innovation capability. Methods: This paper firstly constructs an
evaluation system of technological innovation capability of biopharmaceutical
industry based on the summary of previous research. The biopharmaceutical
industry data from 2014 to 2019 were used to analyze the technological innovation capacity of
biopharmaceutical industry in each province and city by using factor analysis
and SPSS24.0 software. Results: The top three technological innovation
capacity scores of provinces and cities in 2014-2019 are Jiangsu, Shandong and
Zhejiang, with 1.95, 1.62 and 1.10 respectively. Conclusion: Provinces
and cities with high innovation capacity are generally concentrated in the
coastal area of East China, forming a high-quality innovation region with
Jiangsu, Zhejiang and Guangdong as typical representatives.
Share and Cite:
Chi, H. and Cao, Y. (2022) Research on the Evaluation of Technological Innovation Capability of China’s Biopharmaceutical Industry.
Advances in Applied Sociology,
12, 84-92. doi:
10.4236/aasoci.2022.124008.
Cited by
No relevant information.